HomeICCC • NASDAQ
add
ImmuCell Corp
Previous close
$5.46
Day range
$5.39 - $5.55
Year range
$3.35 - $5.72
Market cap
49.40M USD
Avg Volume
29.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 7.75M | 52.10% |
Operating expense | 2.21M | -2.25% |
Net income | 514.56K | 145.14% |
Net profit margin | 6.64 | 129.68% |
Earnings per share | — | — |
EBITDA | 1.70M | 758.04% |
Effective tax rate | 1.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.76M | 283.99% |
Total assets | 45.10M | 2.95% |
Total liabilities | 17.58M | -6.55% |
Total equity | 27.52M | — |
Shares outstanding | 8.98M | — |
Price to book | 1.78 | — |
Return on assets | 5.74% | — |
Return on capital | 6.08% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 514.56K | 145.14% |
Cash from operations | -3.05K | 99.58% |
Cash from investing | -196.22K | -680.81% |
Cash from financing | 148.87K | 146.31% |
Net change in cash | -50.40K | 95.01% |
Free cash flow | -112.75K | -265.42% |
About
Founded
1982
Headquarters
Website
Employees
72
